Amanote Research
Register
Sign In
Tamoxifen-Regulated Adenoviral E1A Chimeras for the Control of Tumor Selective Oncolytic Adenovirus Replication in Vitro and in Vivo
Gene Therapy
- United Kingdom
doi 10.1038/sj.gt.3302604
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Genetics
Molecular Biology
Date
September 1, 2005
Authors
I Sipo
X Wang
A Hurtado Picó
L Suckau
S Weger
W Poller
H Fechner
Publisher
Springer Science and Business Media LLC
Related search
Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
The Oncolytic Adenovirus Targeting to TERT and RB Pathway Induced Specific and Potent Anti-Tumor Efficacy in Vitro and in Vivo for Hepatocellular Carcinoma
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Oncolytic Adenovirus Armed With IL-24 Inhibits the Growth of Breast Cancer in Vitro and in Vivo
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Ad3-hTERT-E1a, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Adenoviral E1A Protein Nuclear Import Is Preferentially Mediated by Importin Α3 in Vitro
Virology
Virology
Adenoviral E1A Function Through Myc
Cancer Research
Cancer Research
Oncology
Late-Phase miRNA-controlled Oncolytic Adenovirus for Selective Killing of Cancer Cells
Oncotarget
Oncology
Effective Gene-Viral Therapy of Leukemia by a New Fiber Chimeric Oncolytic Adenovirus Expressing TRAIL: In Vitro and in Vivo Evaluation
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Fully Replication-Competent Adenovirus Vector With Enhanced Oncolytic Properties
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
